Printed from Voxsanity (voxsanity.com.au) — NCT07411365 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Parkinsons Disease
Parkinson's Disease Trial, Not Yet Recruiting
NCT07411365
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- A neurologist has confirmed the person has Parkinson's disease (PD).
- The person has had a Parkinson's disease diagnosis for at least one year.
- The person is between 51 and 80 years of age.
- German is the person's first language (mother tongue).
- The person has been diagnosed with mild cognitive impairment related to Parkinson's disease (PD-MCI), assessed using a specific set of criteria from the Movement Disorder Society (Level II).
- The person has some difficulty with everyday tasks (activities of daily living), as measured by a specific assessment tool called the FAQ quotient.
- The person has someone living with them (such as a family member or carer) who has agreed to provide information about how the person manages daily activities.
- The person has access to a WiFi network at home.
- The person has normal vision and hearing, or these are corrected well enough with glasses or hearing aids.
- The person is able to read and understand written text at an adequate level.
- The person is able to communicate clearly with the research team and is able to understand and follow the requirements of the study.
- The person is willing and able to provide written consent to participate, and understands they have the right to withdraw from the study at any time without it affecting their future medical care.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- The person has been diagnosed with Parkinson's disease dementia (PDD).
- The person is currently taking anti-dementia medications.
- The person has had or is currently receiving deep brain stimulation treatment.
- The person has a history of any brain condition other than Parkinson's disease, such as a head injury, stroke, or brain infection, or has a muscular disease such as myasthenia gravis or myopathy.
- The person has a pre-existing condition that limits movement in their arms or legs, such as muscle injuries or problems with the knees or hips.
- The person has a severe heart condition involving heart failure.
- The person has a severe respiratory (breathing) condition, such as asthma or significant lung disease.
- The person has another serious illness that significantly affects how well their lungs work.
- The person has kidney insufficiency (the kidneys are not working well enough).
- The person is currently in the active stage of an infectious disease.
- The person is currently in the active stage of cancer.
- The person has another illness that causes significant physical weakness.
- The person has a history of a brain condition other than Parkinson's disease, such as a head injury, stroke, or brain infection (confirm with trial site, as this criterion appears in the source criteria twice).
- The person has a dependency on or misuse of alcohol, medications, or drugs (not including nicotine).
- The person shows signs of severe depression based on a specific depression assessment tool (the 15-item Geriatric Depression Scale, with a score of 5 or more).
- The person is currently experiencing acute psychosis.
- The person has any condition or difficulty that would prevent them from completing consent forms or other study requirements.
- The person has another neurodegenerative disease that makes it difficult for them to communicate with the research team or follow study requirements.
- The person has taken part in a clinical trial of a new treatment or medication within the four weeks before the study's first visit, or there are other local rules that would prevent participation.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
Contact this trial
Phone: +497071298ß424
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
University Hospital Tuebingen
Registry
ClinicalTrials.gov
Start date
1 March 2026
Est. completion
31 August 2027
Where this trial is recruiting
🇩🇪 Germany
Primary endpoints
Informant rated cognition score of the Functional Activity Questionnaire (FAQ); Auditory Stroop Test
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.